Please login to the form below

Not currently logged in
Email:
Password:

Novartis appoints new comms chief

Michael Willi replaces Michele Galen
Michael_Willi_Novartis

Swiss pharma company Novarits has named Michael Willi as its new global head of communications, effective June 1.

He replaces Michele Galen who had been in the role for two years. According to PRWeek, Galen has chosen to return to the US for family reasons.

Willi was most recently chief communications officer at the Swiss banking firm UBS, spending 15 years at the company. He left in April 2013 amid struggles among senior management related to a company restructure following major losses.

Since leaving UBS, Willi has worked as an independent consultant on communications and corporate reputation.

His appointment at Novartis marks his first role in the life sciences sector. Among his most pressing concerns will be handing the communications aspects of Novartis' recent deal to acquire the oncology portfolio of GSK and to sell its vaccines portfolio.

23rd May 2014

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics